Stock Scorecard
Stock Summary for Resmed Inc (RMD) - $241.55 as of 11/20/2024 8:39:28 PM EST
Total Score
16 out of 30
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for RMD
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RMD (64 out of 90)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 1 |
| Operating Margin (Max of 10) | 6 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 5 |
Latest News for for RMD
Financial Details for RMD
Company Overview |
|
|---|---|
| Ticker | RMD |
| Company Name | Resmed Inc |
| Country | USA |
| Description | ResMed is a San Diego, California-based medical equipment company. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea (such as CPAP devices and masks), chronic obstructive pulmonary disease (COPD), and other respiratory conditions. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | 1/22/2025 |
Stock Price History |
|
| Last Day Price | 241.55 |
| Price 4 Years Ago | 205.45 |
| Last Day Price Updated | 11/20/2024 8:39:28 PM EST |
| Last Day Volume | 549,312 |
| Average Daily Volume | 1,063,777 |
| 52-Week High | 259.93 |
| 52-Week Low | 150.54 |
| Last Price to 52 Week Low | 60.46% |
Valuation Measures |
|
| Trailing PE | 31.13 |
| Industry PE | 52.46 |
| Sector PE | 40.32 |
| 5-Year Average PE | 49.80 |
| Free Cash Flow Ratio | 83.29 |
| Industry Free Cash Flow Ratio | 35.05 |
| Sector Free Cash Flow Ratio | 27.97 |
| Current Ratio Most Recent Quarter | 2.92 |
| Total Cash Per Share | 2.90 |
| Book Value Per Share Most Recent Quarter | 35.39 |
| Price to Book Ratio | 6.63 |
| Industry Price to Book Ratio | 5.44 |
| Sector Price to Book Ratio | 20.88 |
| Price to Sales Ratio Twelve Trailing Months | 7.31 |
| Industry Price to Sales Ratio Twelve Trailing Months | 13.48 |
| Sector Price to Sales Ratio Twelve Trailing Months | 7.11 |
| Analyst Buy Ratings | 5 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 146,796,000 |
| Market Capitalization | 35,458,573,800 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 11/7/2024 |
| Last Dividend Amount | 0.53 |
| Current Dividend Amount | 0.53 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 2.02 |
| Trailing Annual Dividend Yield | 0.84% |
| Forward Annual Dividend Rate | 2.12 |
| Forward Annual Dividend Yield | 0.88% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 0.84% |
| 5-Year Average Dividend Yield | 0.85% |
| 1-Year Dividend Growth Rate Percentage | 6.98% |
| 3-Year Dividend Growth Rate Percentage | 6.57% |
| 5-Year Dividend Growth Rate Percentage | 4.89% |
| All-Time Dividend Growth Rate Percentage | 16.59% |
| Dividend Payout Ratio | 26.27% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 41.60% |
| Annual Earnings Growth | 13.75% |
| Reported EPS 12 Trailing Months | 7.69 |
| Reported EPS Past Year | 2.20 |
| Reported EPS Prior Year | 7.73 |
| Net Income Twelve Trailing Months | 1,112,883,000 |
| Net Income Past Year | 1,020,951,000 |
| Net Income Prior Year | 897,556,000 |
| Quarterly Revenue Growth YOY | 11.10% |
| 5-Year Revenue Growth | 12.42% |
| Operating Margin Twelve Trailing Months | 0.32 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 426,361,000 |
| Total Cash Past Year | 238,361,000 |
| Total Cash Prior Year | 227,891,000 |
| Net Cash Position Most Recent Quarter | -241,217,000 |
| Net Cash Position Past Year | -458,952,000 |
| Long Term Debt Past Year | 697,313,000 |
| Long Term Debt Prior Year | 1,431,234,000 |
| Total Debt Most Recent Quarter | 667,578,000 |
| Equity to Debt Ratio Past Year | 0.87 |
| Equity to Debt Ratio Most Recent Quarter | 0.89 |
| Total Stockholder Equity Past Year | 4,864,043,000 |
| Total Stockholder Equity Prior Year | 4,129,903,000 |
| Total Stockholder Equity Most Recent Quarter | 5,195,026,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,346,918,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.18 |
| Free Cash Flow Past Year | 1,286,404,000 |
| Free Cash Flow Prior Year | 559,299,000 |
Options |
|
| Put/Call Ratio | 0.39 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.13 |
| MACD Signal | 1.82 |
| 20-Day Bollinger Lower Band | 193.43 |
| 20-Day Bollinger Middle Band | 230.21 |
| 20-Day Bollinger Upper Band | 266.98 |
| Beta | 0.69 |
| RSI | 41.76 |
| 50-Day SMA | 203.87 |
| 150-Day SMA | 206.08 |
| 200-Day SMA | 211.93 |
System |
|
| Modified | 11/19/2024 11:40:34 AM EST |